Showing results (1-10 of 9) with videos related to
Sort By:
Pageof 1
Frontiers in Immunology|April 10, 2020
Myeloid-Derived Suppressor Cells as Target of Phosphodiesterase-5 Inhibitors in Host-Directed Therapeutics for TuberculosisVinzeigh Leukes, Gerhard Walzl, Nelita du PlessisFrontiers in Cellular and Infection Microbiology|October 10, 2018
Translational Potential of Therapeutics Targeting Regulatory Myeloid Cells in TuberculosisNelita du Plessis, Leigh A Kotze, Vinzeigh Leukes, et al.Research Square|April 10, 2026
Accuracy and clinical utility of near-point-of-care blood tests for predicting incident tuberculosis in exposed contacts in high burden settings: a multi-country observational cohort studyShima Abdulgader, Arthur Chiwaya, Marc Banuls, et al.BMJ Global Health|November 19, 2025
An extended cost-effectiveness analysis of decentralised TB diagnostic testing with Molbio Truenat MTB/RIF versus hub-and-spoke GeneXpert MTB/RIF in Mozambique and TanzaniaSaima Bashir, Lelisa Fekadu Assebe, Akash Malhotra, et al.The European Respiratory Journal|July 4, 2024
Blood transcriptomic signatures for symptomatic tuberculosis in an African multicohort studyVanessa Mwebaza Muwanga, Simon C Mendelsohn, Vinzeigh Leukes, et al.Plos One|February 25, 2021
Higher SARS-CoV-2 seroprevalence in workers with lower socioeconomic status in Cape Town, South AfricaJane Alexandra Shaw, Maynard Meiring, Tracy Cummins, et al.BMJ Global Health|May 11, 2026
User perspectives on the Molbio Truenat platform and tuberculosis assays for decentralised testing in Mozambique and TanzaniaMaria Del Mar Castro, Celso Khosa, Grace Mhalu, et al.BMC Infectious Diseases|August 15, 2024
Expanding Xpert MTB/RIF Ultra® and LF-LAM testing for diagnosis of tuberculosis among HIV-positive adults admitted to hospitals in Tanzania and Mozambique: a randomized controlled trial (the EXULTANT trial)Chacha Mangu, Marta Cossa, Robert Ndege, et al.The Lancet. Infectious Diseases|May 9, 2026
Expanding Xpert MTB/RIF Ultra and lateral flow urine lipoarabinomannan testing for diagnosis of tuberculosis among adults living with HIV admitted to hospitals in Tanzania and Mozambique (EXULTANT): a randomised controlled trialMarta Cossa, Robert Ndege, Bindiya Meggi, et al.Pageof 1